RUNX1 and acute lymphoblastic leukemia: Thus, RUNX1 needs to be taken into consideration as a recombinase cofactor for a better understanding of molecular mechanisms leading to physiological (e.g. TCRβ, TCRδ) and aberrant (e.g. ETV6-RUNX1 ALL) deletions.